A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin
- PMID: 10702551
- DOI: 10.1093/jac/45.3.321
A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin
Abstract
A retrospective analysis of the relationship between estimated pharmacokinetic/pharmacodynamic indices and the reported efficacy of ciprofloxacin has been carried out using different correlation models. f1.gif" BORDER="0">, T(ss) > MIC, f2.gif" BORDER="0"> and AUIC(ss) were calculated for each clinical case included in the study, from simulated plasma level curves corresponding to the dosage regimen administered. A univariate correlation analysis was performed considering efficacy (%) as the dependent variable and indices as the independent variables according to linear and non-linear pharmacokinetic-pharmacodynamic models (PK-PD models). The results prove that log-transformation of the independent variable improves the data fitting to linear model. The four estimated indices show a log-linear relationship with outcome, T(ss) > MIC and AUIC(ss) being the parameters best correlated with percentage efficacy. The E(max) model with intrinsic response is an additional correlation strategy for T(ss) > MIC, leading to estimated values of E(max) and E(0) of 100.34 +/- 25.09% and 24.40 +/- 11.7%, respectively. The wide range of bacteria responsible for the infections considered, including Gram-positive pathogens such as staphylococci, might explain the good correlation between T(ss) > MIC and percentage efficacy found for ciprofloxacin in this study.
Similar articles
-
A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.Clin Pharmacokinet. 2001;40(2):125-34. doi: 10.2165/00003088-200140020-00004. Clin Pharmacokinet. 2001. PMID: 11286322 Review.
-
Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.J Vet Intern Med. 2006 Nov-Dec;20(6):1297-306. doi: 10.1892/0891-6640(2006)20[1297:copapi]2.0.co;2. J Vet Intern Med. 2006. PMID: 17186841
-
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.Antimicrob Agents Chemother. 1993 May;37(5):1073-81. doi: 10.1128/AAC.37.5.1073. Antimicrob Agents Chemother. 1993. PMID: 8517694 Free PMC article. Clinical Trial.
-
Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia.J Med Assoc Thai. 2010 Jul;93(7):784-8. J Med Assoc Thai. 2010. PMID: 20649056 Clinical Trial.
-
Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.Ann Pharmacother. 2003 Sep;37(9):1287-98. doi: 10.1345/aph.1C199. Ann Pharmacother. 2003. PMID: 12921513 Review.
Cited by
-
Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients.Clin Pharmacokinet. 2002;41(14):1213-20. doi: 10.2165/00003088-200241140-00005. Clin Pharmacokinet. 2002. PMID: 12405867
-
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration.BMC Clin Pharmacol. 2011 Aug 4;11:11. doi: 10.1186/1472-6904-11-11. BMC Clin Pharmacol. 2011. PMID: 21816053 Free PMC article. Clinical Trial.
-
Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice.Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01804-20. doi: 10.1128/AAC.01804-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33106267 Free PMC article.
-
A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.Clin Pharmacokinet. 2001;40(2):125-34. doi: 10.2165/00003088-200140020-00004. Clin Pharmacokinet. 2001. PMID: 11286322 Review.
-
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.Antimicrob Agents Chemother. 2004 Feb;48(2):369-77. doi: 10.1128/AAC.48.2.369-377.2004. Antimicrob Agents Chemother. 2004. PMID: 14742182 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous